vs
Side-by-side financial comparison of MEDIFAST INC (MED) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $39.6M, roughly 1.9× SBC Medical Group Holdings Inc). On growth, SBC Medical Group Holdings Inc posted the faster year-over-year revenue change (-10.9% vs -36.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $-6.6M). Over the past eight quarters, SBC Medical Group Holdings Inc's revenue compounded faster (-15.0% CAGR vs -34.4%).
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
MED vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $39.6M |
| Net Profit | — | $14.2M |
| Gross Margin | 69.4% | 73.1% |
| Operating Margin | -10.4% | 32.5% |
| Net Margin | — | 35.9% |
| Revenue YoY | -36.9% | -10.9% |
| Net Profit YoY | — | 117.2% |
| EPS (diluted) | $-1.64 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $39.6M | ||
| Q3 25 | $89.4M | $43.4M | ||
| Q2 25 | $105.6M | $43.4M | ||
| Q1 25 | $115.7M | $47.3M | ||
| Q4 24 | $119.0M | $44.4M | ||
| Q3 24 | $140.2M | $53.1M | ||
| Q2 24 | $168.6M | $53.1M | ||
| Q1 24 | $174.7M | $54.8M |
| Q4 25 | — | $14.2M | ||
| Q3 25 | $-2.3M | $12.8M | ||
| Q2 25 | $2.5M | $2.5M | ||
| Q1 25 | $-772.0K | $21.5M | ||
| Q4 24 | — | $6.5M | ||
| Q3 24 | $1.1M | $2.8M | ||
| Q2 24 | $-8.2M | $18.5M | ||
| Q1 24 | $8.3M | $18.8M |
| Q4 25 | 69.4% | 73.1% | ||
| Q3 25 | 69.5% | 70.6% | ||
| Q2 25 | 72.6% | 69.2% | ||
| Q1 25 | 72.8% | 79.7% | ||
| Q4 24 | 74.1% | 76.3% | ||
| Q3 24 | 75.4% | 81.5% | ||
| Q2 24 | 73.2% | 74.2% | ||
| Q1 24 | 72.8% | 72.1% |
| Q4 25 | -10.4% | 32.5% | ||
| Q3 25 | -4.6% | 36.6% | ||
| Q2 25 | -1.0% | 33.6% | ||
| Q1 25 | -1.1% | 51.1% | ||
| Q4 24 | 0.6% | 10.6% | ||
| Q3 24 | 1.5% | 26.1% | ||
| Q2 24 | -4.7% | 51.4% | ||
| Q1 24 | 4.5% | 44.6% |
| Q4 25 | — | 35.9% | ||
| Q3 25 | -2.5% | 29.6% | ||
| Q2 25 | 2.3% | 5.7% | ||
| Q1 25 | -0.7% | 45.4% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | 0.8% | 5.3% | ||
| Q2 24 | -4.8% | 34.8% | ||
| Q1 24 | 4.8% | 34.2% |
| Q4 25 | $-1.64 | $0.15 | ||
| Q3 25 | $-0.21 | $0.12 | ||
| Q2 25 | $0.22 | $0.02 | ||
| Q1 25 | $-0.07 | $0.21 | ||
| Q4 24 | $0.08 | $0.05 | ||
| Q3 24 | $0.10 | $0.03 | ||
| Q2 24 | $-0.75 | $0.20 | ||
| Q1 24 | $0.76 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $198.9M | $248.3M |
| Total Assets | $248.0M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $164.1M | ||
| Q3 25 | $173.5M | $127.4M | ||
| Q2 25 | $162.7M | $152.7M | ||
| Q1 25 | $164.6M | $132.1M | ||
| Q4 24 | $162.3M | $125.0M | ||
| Q3 24 | $170.0M | $137.4M | ||
| Q2 24 | $163.5M | — | ||
| Q1 24 | $156.4M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $198.9M | $248.3M | ||
| Q3 25 | $214.7M | $248.0M | ||
| Q2 25 | $216.0M | $244.6M | ||
| Q1 25 | $211.0M | $226.4M | ||
| Q4 24 | $210.1M | $195.1M | ||
| Q3 24 | $207.3M | $205.0M | ||
| Q2 24 | $205.3M | $8.8M | ||
| Q1 24 | $211.0M | $9.0M |
| Q4 25 | $248.0M | $380.4M | ||
| Q3 25 | $268.2M | $321.4M | ||
| Q2 25 | $269.3M | $315.3M | ||
| Q1 25 | $280.0M | $284.6M | ||
| Q4 24 | $284.2M | $266.1M | ||
| Q3 24 | $291.2M | $296.5M | ||
| Q2 24 | $293.5M | $19.5M | ||
| Q1 24 | $302.8M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.3M | $52.0M |
| Free Cash FlowOCF − Capex | $-6.6M | $51.2M |
| FCF MarginFCF / Revenue | -8.8% | 129.3% |
| Capex IntensityCapex / Revenue | 1.8% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $1.2M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.3M | $52.0M | ||
| Q3 25 | $12.1M | $-20.9M | ||
| Q2 25 | $-3.4M | $-8.3M | ||
| Q1 25 | $3.4M | $1.9M | ||
| Q4 24 | $-4.9M | $-7.3M | ||
| Q3 24 | $9.1M | $5.0M | ||
| Q2 24 | $13.1M | $19.2M | ||
| Q1 24 | $7.3M | $3.7M |
| Q4 25 | $-6.6M | $51.2M | ||
| Q3 25 | $10.8M | $-20.9M | ||
| Q2 25 | $-4.8M | $-8.6M | ||
| Q1 25 | $1.9M | $1.7M | ||
| Q4 24 | $-7.2M | $-7.9M | ||
| Q3 24 | $7.7M | $4.6M | ||
| Q2 24 | $11.1M | $18.3M | ||
| Q1 24 | $5.4M | $3.0M |
| Q4 25 | -8.8% | 129.3% | ||
| Q3 25 | 12.0% | -48.3% | ||
| Q2 25 | -4.5% | -19.9% | ||
| Q1 25 | 1.6% | 3.5% | ||
| Q4 24 | -6.1% | -17.8% | ||
| Q3 24 | 5.5% | 8.7% | ||
| Q2 24 | 6.6% | 34.5% | ||
| Q1 24 | 3.1% | 5.4% |
| Q4 25 | 1.8% | 2.0% | ||
| Q3 25 | 1.5% | 0.1% | ||
| Q2 25 | 1.3% | 0.7% | ||
| Q1 25 | 1.3% | 0.5% | ||
| Q4 24 | 1.9% | 1.3% | ||
| Q3 24 | 1.0% | 0.8% | ||
| Q2 24 | 1.1% | 1.6% | ||
| Q1 24 | 1.1% | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | -1.36× | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | 8.04× | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | 0.88× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MED
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
